Biostage, Inc. BSTG
4.03 +4.03
Quote time unavailable
Day range unavailable
52-week range unavailable
News
defenseworld.net Contrasting Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) & Biostage (OTCMKTS:BSTG) Defiance Daily Target 2X Long LMND ETF (NASDAQ: LMNX - Get Free Report) and Biostage (OTCMKTS:BSTG - Get Free Report) are both small-cap medical companies, but which is the superior business? We will…
defenseworld.net Financial Analysis: Biostage (OTCMKTS:BSTG) and T2 Biosystems (NASDAQ:TTOO) T2 Biosystems (NASDAQ: TTOO - Get Free Report) and Biostage (OTCMKTS:BSTG - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two…
defenseworld.net Critical Comparison: Arch Therapeutics (OTCMKTS:ARTH) vs. Biostage (OTCMKTS:BSTG) Arch Therapeutics (OTCMKTS:ARTH - Get Free Report) and Biostage (OTCMKTS:BSTG - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two…
prnewswire.com Biostage Activated Mayo Clinic as The First Site for Clinical Trial in Severe Esophageal Disease HOLLISTON, Mass. , July 18, 2023 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a clinical-stage biotechnology company developing the technology to regenerate organs…
prnewswire.com Biostage Selects IQVIA to Manage its FDA-Approved Clinical Trial in Severe Esophageal Disease, including Cancer IQVIA was selected because of its dedicated gastrointestinal team and depth of experience in running cell-therapy clinical trials. HOLLISTON, Mass.
seekingalpha.com Biostage, Inc. (BSTG) Q3 2022 Earnings Call Transcript Biostage, Inc. (OTC:BSTG) Q3 2022 Earnings Conference Call November 15, 2022 9:00 AM ET Company Participants David Green - Interim Chief Executive Officer Joe Damasio - Chief Financial Officer…
prnewswire.com Biostage Schedules Conference Call and Webcast for Q2 2022 Results HOLLISTON, Mass. , Aug. 4, 2022 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company with successful "first-in-human" experience in…
seekingalpha.com Biostage Begins U.S. Uplisting IPO Rollout Biostage has filed to raise capital via an uplisting IPO to Nasdaq. The firm is developing treatments for the various gastrointestinal system and airway conditions.
seekingalpha.com Biostage, Inc. (BSTG) Interim CEO David Green on Q1 2022 Results - Earnings Call Transcript Biostage, Inc. (OTC:BSTG) Q1 2022 Earnings Conference Call May 17, 2022 8:30 AM ET Company Participants Peter Pellegrino - Interim Vice President of Finance David Green - Interim Chief Executive…
prnewswire.com Biostage Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2021 Financial Results HOLLISTON, Mass. , March 30, 2022 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company with successful "first-in-human" experience in…
prnewswire.com Biostage Reports Q2 2021 Financial Results HOLLISTON, Mass., Aug. 13, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants based its novel…
prnewswire.com Biostage Reports Q1 2021 Financial Results HOLLISTON, Mass., May 24, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants based its novel…
benzinga.com Stocks That Hit 52-Week Highs On Thursday 
benzinga.com 35 Stocks Moving In Thursday's Mid-Day Session